New opportunities of systemic therapy of CD30-positive primary cutaneous T-cell lymphomas

New opportunities of systemic therapy of CD30-positive primary cutaneous T-cell lymphomas

Relevance. Cutaneous T-cell lymphomas (CTCL) are not common diseases which are associated with a decrease in quality of life. Currently available systemic therapy rarely provides a stable and long-termed response. In Russia, current CTCL therapy is a big issue due to the limited access to modern tar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irina V. Poddubnaya, Vadim V. Ptushkin, Irena E. Belousova, L. G. Gorenkova, Kamil D. Kaplanov, A. E. Karamova, Alla M. Kovrigina, O. A. Kolomeitsev, T. S. Konstantinova, Muza M. Kokhan, Tatyana I. Pospelova
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2020
Materias:
brentuximab vedotin
cd30 + primary cutaneous t-cell lymphoma
mycosis fungoides
sézary syndrome
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/f921cc1b2d574f329683c8677d437862
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f921cc1b2d574f329683c8677d437862

Ejemplares similares